Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Vaxart, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 17 | 5 | −12 |
| Shares | 2.34M | 63.0K | −2.28M (−97.3%) |
| Value | $839.9K | $22.2K | −$817.7K (−97.4%) |
New holders (1)
Institutions that held Vaxart, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kingswood Wealth Advisors, LLC | 10,005 | $3.47K | 0.00% |
Sold out (13)
Institutions that held Vaxart, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Marshall Wace, LLP | 1,953,037 | $703.1K |
| XTX Topco Ltd | 94,258 | $34.4K |
| HBK Sorce Advisory LLC | 75,118 | $26.2K |
| Beacon Capital Management, LLC | 60,314 | $22.0K |
| Custos Family Office, LLC | 50,000 | $18.2K |
| Simplex Trading, LLC | 18,592 | $6.00K |
| Advisor Group Holdings, Inc. | 14,185 | $5.30K |
| Wealth Enhancement Advisory Services, LLC | 10,400 | $3.65K |
| Baader Bank INC | 12,091 | $2.73K |
| Rockefeller Capital Management L.P. | 1,175 | $429 |
| Umb Bank N A | 100 | $36 |
| Concord Wealth Partners | 75 | $27 |
| Farther Finance Advisors, LLC | 27 | $10 |